Partha Basu, Head of the Early Detection, Prevention and Infections Branch at IARC – International Agency for Research on Cancer / World Health Organization, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Pleased to share the International Agency for Research on Cancer / World Health Organization study in collaboration with Chittaranjan National Cancer Institute =, India that clearly demonstrated the comparable efficacy of HPV testing on urine samples and self-collected vaginal samples.
The landscape of HPV screening is going to be transformed.”
Title: Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting
Authors: Sreeya Bose, Ranajit Mandal, Sankar Sengupta, Sankhadeep Dutta, Priya Abraham, Richard Muwonge, Eric Lucas, Chinmay Kumar Panda, Sathishrajaa Palaniraja, Maryluz Rol, Jayanta Chakrabarti, Partha Basu
Read the Full Article on BMJ Glob Health
More posts featuring Partha Basu.